Shareholders meeting

17th September 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: SAILIFE BSE Scrip code: 544306 Dear Sir/Madam, Ref: Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Sub: Summary of the Proceedings of the 27th Annual General Meeting (“AGM”). Pursuant to Regulation 30 of the SEBI Listing Regulations, we are enclosing herewith the summary of proceedings of the 27th AGM of the members of Sai Life Sciences Limited held on Thursday, September 17, 2026, at 10:30 A.M. (IST), through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). Kindly take the above information on your record. Thanking you. Yours sincerely, For Sai Life Sciences Limited Runa Karan Company Secretary & Compliance Officer Membership No. A13721 Encl.: As above Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. SUMMARY OF PROCEEDINGS OF 27th ANNNUAL GENERAL MEETING OF SAI LIFE SCIENCES LIMITED The 27th Annual General Meeting (“AGM”) of the members of Sai Life Sciences Limited (“Company”) was held on Thursday, September 17, 2026, at 10:30 A.M. (IST), through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). The following Directors were present: 1. Dr. Kanumuri Ranga Raju, Chairman & Whole Time Director 2. Mr. Krishnam Raju Kanumuri, Managing Director & Chief Executive Officer 3. Mr. Sivaramakrishnan Chittor, Whole-time Director & Chief Financial Officer 4. Mr. Dinesh Vinoobhai Patel, Independent Director 5. Mr. Ramesh Ganesh Iyer, Independent Director 6. Ms. Suchita Sharma, Independent Director In Attendance: 1. Ms. Runa Karan, Company Secretary & Compliance Officer 2. Ms. Madhavi Kalva, Representative of Statutory Auditors 3. Mr. DS Rao, Representative of Secretarial Auditors 4. Mr. DSM Ram, Scrutinizer of the Meeting The meeting was attended by 94 (Ninety-four) members holding 7,76,98,047 equity shares, through VC/OAVM. The Company Secretary & Compliance Officer welcomed all the members to the 27th AGM of the Company and informed the members that meeting is being held through Video conference / Other audio-visual means, in compliance with the circulars issued by the Ministry of Corporate Affairs (“MCA”) and Securities Exchange Board of India (“SEBI”) from time to time. Further, it was informed that the Notice of the 27th AGM together with the Integrated Annual report of the Company for the financial year 2025-2026 has been sent electronically to those Members whose e-mail IDs are registered with the Company’s Registrar & Transfer Agent (RTA) or with the Depositories and a letter containing the Quick Response code (QR code and the complete path to access the Integrated Annual Report, along with the Notice of the AGM, has been sent to those shareholders who have not registered their e-mail addresses with the Company, RTA, or Depositories. The 27th AGM Notice and Auditor’s Report were taken as read. Members were requested to note that were no qualifications, observations, or adverse comments on the financial statements in the Auditor’s report. Further, there were no qualifications, observations, or adverse remarks on the Secretarial Audit Report given by the secretarial auditor of the Company. Further, the members were informed that the Register of Directors’ and KMP and their Shareholding maintained under Section 170 of the Companies Act, 2013, Register of contracts maintained under Section 189 of the Companies Act, 2013 and Compliance Certificate obtained from Secretarial Auditor in compliance with Regulation 13 of the SEBI (Share Based Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. Employee Benefits and Sweat Equity) Regulations, 2021, were available for inspection electronically by all the Members at any time during that meeting. The Members were further informed that, pursuant to Section 108 of the Companies Act, 2013 read with the applicable Rules thereunder and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had provided the facility to cast votes electronically on all the resolutions set out in the Notice of the 27th AGM, through its e-voting service provider, KFin Technologies Limited (“KFin”). The remote e-voting facility remained open from 9:00 A.M. (IST) on September 14, 2026, to 5:00 P.M. (IST) on September 16, 2026. Members were informed that the Board of Directors had appointed Mr. DSM Ram, Practising Company Secretary, as the Scrutinizer for the purpose of scrutinizing the process of remote e- voting and e-voting during this AGM. It was further informed that the Members who had already exercised their right to vote through remote e-voting and were also present at the AGM, could participate in the meeting; however, they were not permitted to cast their votes again. As the requisite quorum for the meeting was present, Chairman called the meeting to order and welcomed all the shareholders to the AGM and addressed all the shareholders through his welcome note. Due to a technical issue, on behalf of Mr. Krishnam Raju Kanumuri, Managing Director & Chief Executive Officer (MD & CEO), Mr. Sivaramakrishnan Chittor, Whole-Time Director & Chief Financial Officer (CFO) addressed the shareholders and presented a detailed overview of the Company's financial performance for the financial year 2025-26. He highlighted the key financial and operational achievements during the year and also shared the Company's growth strategy, business outlook, and future opportunities that are expected to drive sustainable growth and value creation for stakeholders. Thereafter, the floor was open for speaker shareholders who had pre-registered themselves as speakers, were given an opportunity to offer their comments and seek clarifications, if any. Few speaker shareholders offered their comments, posed various questions, and sought various clarifications from the company. Mr. Krishnam Raju Kanumuri, MD & CEO, of the Company had addressed all the queries and provided the respective clarifications raised by speaker shareholders satisfactorily. The following businesses as set out in the 27th AGM Notice were transacted: Ordinary Business: 1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the year ended 31st March 2026, together with the reports of the Board of Directors and the auditors thereon and the Audited Consolidated Financial Statements of the Company for the year ended 31st March 2026 together with the report of the auditors thereon. Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. 2. To appoint a director in place of Mr. Krishnamraju Kanumuri (DIN: 00064614), who retires by rotation and being eligible, offers himself for re-appointment. Further, it was informed that the shareholders who were pre [Showing first 8,000 characters — download PDF for full document]